IL132099A0 - Methods for assessing cardiovascular status and compositions for use therein - Google Patents

Methods for assessing cardiovascular status and compositions for use therein

Info

Publication number
IL132099A0
IL132099A0 IL13209998A IL13209998A IL132099A0 IL 132099 A0 IL132099 A0 IL 132099A0 IL 13209998 A IL13209998 A IL 13209998A IL 13209998 A IL13209998 A IL 13209998A IL 132099 A0 IL132099 A0 IL 132099A0
Authority
IL
Israel
Prior art keywords
cardiovascular status
methods
compositions
agt
nucleic acid
Prior art date
Application number
IL13209998A
Other languages
English (en)
Original Assignee
Pyro Sequencing Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pyro Sequencing Ab filed Critical Pyro Sequencing Ab
Publication of IL132099A0 publication Critical patent/IL132099A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
IL13209998A 1997-04-04 1998-04-01 Methods for assessing cardiovascular status and compositions for use therein IL132099A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4293097P 1997-04-04 1997-04-04
PCT/IB1998/000475 WO1998045477A2 (en) 1997-04-04 1998-04-01 Methods for assessing cardiovascular status and compositions for use thereof

Publications (1)

Publication Number Publication Date
IL132099A0 true IL132099A0 (en) 2001-03-19

Family

ID=21924511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13209998A IL132099A0 (en) 1997-04-04 1998-04-01 Methods for assessing cardiovascular status and compositions for use therein

Country Status (13)

Country Link
US (1) US6197505B1 (da)
EP (1) EP0972075B1 (da)
JP (1) JP2001519660A (da)
AT (1) ATE335844T1 (da)
AU (1) AU741750B2 (da)
CA (1) CA2285671A1 (da)
CY (1) CY1106158T1 (da)
DE (1) DE69835509T2 (da)
DK (1) DK0972075T3 (da)
ES (1) ES2270510T3 (da)
IL (1) IL132099A0 (da)
NZ (1) NZ337878A (da)
WO (1) WO1998045477A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197505B1 (en) 1997-04-04 2001-03-06 Pyrosequencing Ab Methods for assessing cardiovascular status and compositions for use thereof
ES2238770T5 (es) * 1997-10-17 2012-01-17 Ark Therapeutics Limited Utilización de inhibidores del sistema renina-angiotensina para el tratamiento de la hipoxia o de la disminución de la función metabólica.
JP2002527079A (ja) * 1998-10-14 2002-08-27 パイロシーケンシング・アーベー 心臓血管ステータスを評価するための遺伝子及びその使用のための組成物
US6280994B1 (en) * 1998-11-25 2001-08-28 Zymogenetics, Inc. Zace 1: a human metalloenzyme
WO2000056922A2 (en) * 1999-03-23 2000-09-28 Gemini Genomics Ab Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
GB9914440D0 (en) * 1999-06-22 1999-08-18 Zeneca Ltd Chemical compounds
US20030113330A1 (en) * 1999-11-08 2003-06-19 Uhal Bruce D. Methods for treating pulmonary fibrosis
US7141370B2 (en) * 2001-07-03 2006-11-28 The Board Of Trustees Of The Leland Stanford Junior University Bioluminescence regenerative cycle (BRC) for nucleic acid quantification
EP1394267A1 (en) * 2002-08-19 2004-03-03 Bayer HealthCare AG Single nucleotide polymorphisms predictive for cardiovascular disease, adverse drug reactions, and drug efficacy
US20040197793A1 (en) * 2002-08-30 2004-10-07 Arjang Hassibi Methods and apparatus for biomolecule detection, identification, quantification and/or sequencing
WO2005083127A2 (en) * 2004-02-27 2005-09-09 Applera Corporation Genetic polymorphisms associated with stroke, methods of detection and uses thereof
CN100540678C (zh) * 2004-04-15 2009-09-16 香港中文大学 应用遗传标记和芯片预测糖尿病肾病危险的方法
WO2006123885A1 (en) * 2005-05-18 2006-11-23 Samsung Electronics Co., Ltd. Methods and compositions for diagnosing cardiovascular disease
US9012143B2 (en) * 2007-04-30 2015-04-21 The Ohio State University Research Foundation Polymorphisms in genes affecting ace-related disorders and uses thereof
WO2010096680A2 (en) 2009-02-20 2010-08-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Protein structural biomarkers to guide targeted chemotherapies
US9938576B1 (en) 2012-09-21 2018-04-10 Ohio State Innovation Foundation Materials and methods for determining metabolizer status in humans

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0234095A3 (en) 1985-10-24 1988-06-15 Biotechnology Research Partners, Ltd. Blood tests diagnostic for hypertension
AU1728088A (en) 1987-04-30 1988-12-02 Biotechnology Research Partners Limited Hypertension-related blood tests useful as genetic markers
FR2678285A1 (fr) * 1991-06-27 1992-12-31 Inst Nat Sante Rech Med Moyens et procedes pour l'etude du polymorphisme genetique de l'enzyme de conversion de l'angiotensine 1.
US5374525A (en) 1992-09-30 1994-12-20 University Of Utah Research Foundation Methods to determine predisposition to hypertension and association of variant angiotensinogen gene and hypertension
US5243652A (en) * 1992-09-30 1993-09-07 Gte Laboratories Incorporated Location-sensitive remote database access control
FR2723590B1 (fr) * 1994-08-09 1996-10-25 Inst Nat Sante Rech Med Procede de detection et trousse de diagnostic in vitro d'une predisposition a l'infarctus du myocarde
US5800990A (en) 1995-12-06 1998-09-01 Regents Of The University Of Colorado Angiotensin-converting enzyme genetic variant screens
US6197505B1 (en) 1997-04-04 2001-03-06 Pyrosequencing Ab Methods for assessing cardiovascular status and compositions for use thereof
EP1044268A1 (de) 1997-12-30 2000-10-18 Max-Delbrück-Centrum Für Molekulare Medizin Neue sequenzvarianten des menschlichen beta2-adrenergen rezeptorgens und ihre verwendung

Also Published As

Publication number Publication date
NZ337878A (en) 2001-09-28
CY1106158T1 (el) 2011-06-08
DK0972075T3 (da) 2006-12-11
US6197505B1 (en) 2001-03-06
DE69835509T2 (de) 2007-04-05
EP0972075B1 (en) 2006-08-09
AU741750B2 (en) 2001-12-06
ATE335844T1 (de) 2006-09-15
AU6632998A (en) 1998-10-30
CA2285671A1 (en) 1998-10-15
EP0972075A2 (en) 2000-01-19
WO1998045477A2 (en) 1998-10-15
ES2270510T3 (es) 2007-04-01
WO1998045477A3 (en) 1999-01-28
JP2001519660A (ja) 2001-10-23
DE69835509D1 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
WO1998045477A3 (en) Methods for assessing cardiovascular status and compositions for use thereof
Giuliani et al. Inferring chronological age from DNA methylation patterns of human teeth
WO2001013086A3 (en) Detection of nucleic acids
ZA972909B (en) Detecting genetic predisposition for osteoporosis
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
DK0805876T3 (da) Nukleinsyreamplifikationsoligonukleotider og prober til Lyme-sygdom-associeret Borrelia
ATE269416T1 (de) Verwendung von vereinigten sonden zur genetischen analyse
MX9708427A (es) Serpina derivada de pancreas.
WO2000022166A3 (en) Genes for assessing cardiovascular status and compositions for use thereof
IN188176B (da)
WO2001000803A3 (en) Apolipoprotein a-iv-related protein: polypeptide, polynucleotide sequences and biallelic markers thereof
IL145141A0 (en) Compositions and methods for genetic analysis
WO2004044163A3 (en) Methods for identifying risk of melanoma and treatments thereof
EP0973794A4 (en) NETRIN RECEPTORS
FR2636968B1 (fr) Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
WO1996040040A3 (en) Thrombin receptor homolog
WO2000009693A3 (en) Identification of the gene causing the mouse scurfy phenotype and its human ortholog
WO2003072828A3 (en) Fcgammariib polymorphisms detection in system lupus erythematosus
AU7286187A (en) Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
ATE449868T1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
MX9709338A (es) Receptor de transmembrana-siete de tipo c5a.
ES2308852T3 (es) Secuencias genomicas y completas de cdna de apm1 humano especifico para adipocitos y marcadores bialelicos de los mismos.
WO2001040522A3 (en) Short shared nucleotide sequences
AU2002335491A1 (en) Test system for determining gene toxicities
DE60025336D1 (de) Verfahren und kit zur früherkennung von krebs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees